Skip to content

Comparison of lidocaine lozenges and lidocaine nebulization for providing better condition during fiberoptic intubation

COMPARING LIDOCAINE LOZENGES AND NEBULIZED LIDOCAINE FOR INTUBATING CONDITIONS DURING AWAKE FIBEROPTIC GUIDED INTUBATION: A PILOT STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045699
Enrollment
80
Registered
2022-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: LIDOCAINE LOZENGES (Each Lozenges of 200mg given orally): IT IS A NEW FORMULATION OF DRUG CAME WHO HAS GOOD COMPALINCE TO PATIENT ACCEPTANCE FOR ANAESTHETISING THE UPPER AIRWAY FOR AWAK

Sponsors

LOK NAYAK HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologist physical status classes (ASA) I & II patients age between 18 and 70 years of either sex scheduled for elective surgery under general anaesthesia with anticipated difficult airway requiring awake nasal/oral fiberoptic intubation

Exclusion criteria

Exclusion criteria: 1. Uncooperative patients 2. Pregnant patients 3. Known Allergy to lidocaine

Design outcomes

Primary

MeasureTime frame
Time taken for successful awake fiberoptic guided intubationTimepoint: defined as time taken from insertion of fiberoptic guided intubation inside nostril/ mouth to square shaped capnograph

Secondary

MeasureTime frame
1. First attempt success rate. 2. Anaesthesiologist satisfaction (Ease of procedure, level of gag reflex, ease of application of anesthetic agent). 3. Hemodynamic variable (heart rate and mean arterial pressure) will be recorded at baseline, 1min, 3min and 5min after the procedure. 4. Patients satisfaction (Tolerability of procedure, aversive symptoms experienced during and/or after procedure, patient�s preference for repetition of procedure). 5. Any signs of lignocaine toxicity such as ECG changes, seizures, and bronchoconstriction if any.Timepoint: from starting of the awake fiberoptic intubation till 5 min of the procedure

Countries

India

Contacts

Public ContactDR DEEPAK KUMAR

DEPARTMENT OF ANAESTHESIA AND INTENSIVE CARE

deepakkumar3090@gmail.com9717864257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026